Manikandan S, Gitanjali B
Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
J Postgrad Med. 2012 Jan-Mar;58(1):68-72. doi: 10.4103/0022-3859.93258.
Essential medicines lists have been shown to improve the quality and cost-effectiveness of health care delivery when combined with proper procurement policies and good prescribing practices. The Ministry of Health, Government of India revised the National List of Essential Medicines of India (NLEMI 2011) in June 2011, eight years after the last revision. The NLEMI 2011 contains 348 medicines and was prepared over one and a half years by 87 experts. Though there are some positive aspects to the list such as the documentation of a detailed description of the revision process, inclusion of many experts from various fields in the review committee, well written description of the essential medicines concept and others, a critical review of the list reveals areas of major and minor concerns. Improper medicine selection like the inclusion of a nearly obsolete medicine such as ether, an anesthetic agent; non-inclusion of pediatric formulations; spelling errors; and errors in the strengths of formulations diminishes the significance of the NLEMI 2011. In its present form, the NLEMI 2011 did not align with the Indian Pharmacopoeia, and the National Health Programs as well as the National Formulary of India 2010. Formatting errors, non-inclusion of an index page, syntax and spelling errors may also undermine the usefulness of the NLEMI 2011 as a reference material. An urgent revision of the NLEMI 2011 is suggested so as to avert misinforming the wider international and local readers.
事实证明，基本药物清单与适当的采购政策和良好的处方习惯相结合时，可提高医疗服务的质量和成本效益。印度政府卫生部于2011年6月修订了《印度基本药物清单》（2011年版），距上次修订已有八年时间。2011年版《印度基本药物清单》包含348种药物，由87位专家历时一年半编制而成。尽管该清单有一些积极方面，如详细记录了修订过程、审查委员会中有来自各个领域的众多专家、对基本药物概念的描述清晰等，但对该清单进行严格审查后发现了一些主要和次要问题。药物选择不当，如列入了一种几乎过时的药物——麻醉剂乙醚；未列入儿科制剂；拼写错误；以及制剂规格错误，这些都削弱了2011年版《印度基本药物清单》的重要性。以目前的形式，2011年版《印度基本药物清单》与《印度药典》、国家卫生计划以及《2010年印度国家处方集》不一致。格式错误、未列入索引页、语法和拼写错误也可能损害2011年版《印度基本药物清单》作为参考资料的实用性。建议对2011年版《印度基本药物清单》进行紧急修订，以免误导更广泛的国际和本地读者。
